Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy.

Indeed, we observed a marginally significant correlation between irAE ROR and objective response rates 14 in anti-PD-1/PD-L1 therapy ( Rs = 0.44; P = 0.049; Supplementary Fig. 1 ).

also in 26,082 other papers